Albany – NY, Oct. 20, 2015 (GLOBE NEWSWIRE) — Transparency Market Research announces the publication of a new research report on the global hospital pharmaceuticals market. The report offers a detailed and a comprehensive overview of the market. It emphatically states that the global hospital pharmaceuticals market was valued at US$26.5 billion in 2013 and is expected to reach US$11.6 billion by 2020, declining at a CAGR of 10.5% from 2014 to 2020.The report, titled “Hospital Pharmaceuticals Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 – 2020”, offers a comprehensive view of the global hospital pharmaceuticals market, its key market drivers, restraints, opportunities, and threats.
Browse Market Research Report on Hospital Pharmaceuticals Market:
http://www.transparencymarketresearch.com/hospital-pharmaceuticals-market.html
The global hospital pharmaceuticals market consists of drugs sold at hospitals and other caretaking units. They include minor and major drugs for treating anything from viral fever to chronic conditions such as diabetes and cancer. According to industry experts, the global hospital pharmaceuticals market has been experiencing a slowdown due to poor economic conditions. However, recent research shows that with expiring patents and loss of exclusivity of several blockbuster drugs, the global market for hospital pharmaceuticals will pick up pace. The expected growth of the global hospital pharmaceuticals market in the coming years will also be triggered by the sudden rise in the prevalence of chronic disorders that need treatment at hospitals. Some of the diseases beneficial for the growth of this market are cancer, renal failure, heart blockages, and Alzheimer’s disease.
A report published by the World Health Organization (WHO) indicated that coronary heart diseases result in 7.5 million deaths around the world per year. Statistics shared by the Centers for Disease Control and Prevention (CDC) also supported this figure, with the addition of the shocking fact that 13,000 Americans die of stroke each year. The CDC clarified that 87% of these deaths are due to ischemic strokes. These figures are a clear indicator of possible growth avenues for the global hospital pharmaceutical market.
Get Sample Report Copy of Hospital Pharmaceuticals Market:
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3535
The rise in the per capita income across the globe is also leading to growth of the global hospital pharmaceuticals market. North America held the biggest market share in 2013, as the region offered excellent reimbursement policies. In addition, the region also saw growth of healthcare awareness, improving per capita incomes, and innovations by key market players, thereby increased spending on healthcare. However, analysts predict Asia Pacific and Rest of the World will grow at a rapid pace due to the growing population base and increasing incidence of several chronic diseases.
The key players in the global hospital pharmaceutical market are Bayer AG, AstraZeneca plc, GlaxoSmithKline plc, Eli Lilly and Company, Johnson & Johnson, Pfizer, Inc., Merck & Co., Inc., and Sanofi-Aventis. The report gives a clear understanding of the competitive landscape of the global hospital pharmaceuticals market by profiling these companies. In addition to this, the research report also gives valuable information regarding the financial outlook of these companies, their marketing strategies, and investment plans for the forecast period.
Browse Upcoming Market Research Reports:-
- Gold Nanoparticles Market: http://www.transparencymarketresearch.com/gold-nanoparticles-market.html
- Gerontology/Aging Market: http://www.transparencymarketresearch.com/gerontology-aging-market.html
- Lipid Panel Test Market: http://www.transparencymarketresearch.com/lipid-panel-test-market.html
The global hospital pharmaceuticals market is segmented into the following categories:
Global Hospital Pharmaceuticals Market, by Major Indications
Cardiology
- Coronary Heart Diseases
- Stroke
- High Blood Pressure
- Heart Failure
- Others
Oncology
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Prostate Cancer
- Others
Nephrology and Urology
- Acute Kidney Failure
- Chronic Kidney Diseases
- Glomerular Diseases
- Diabetes
- Others
Neurology
- Epilepsy
- Alzheimer;s Disease
- Parkinson;s Disease
- Multiple Sclerosis
- Detail10
Pain
- Neuropathic Pain
- Fibromyalgia
- Osteoarthritis
- Rheumatoid Arthritis
Cancer Pain
- Infection
- Detail1Tuberculosis
- Pneumonia
- Hepatitis A
- Hepatitis B
- Candida Infection
- Fungal Meningitis
- Shigellosis
- Amoebiasis
- Other
Global Hospital Pharmaceuticals Market, by Geography
- North America
- Europe
- Asia Pacific
- Rest of the World (RoW)
About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.
CONTACT: Mr. Nachiket Ghumare
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: [email protected]
Website: http://www.transparencymarketresearch.com
Sitemap: http://www.transparencymarketresearch.com/sitemap.html